SAN DIEGO, CALIFORNIA (AP). SAN DIEGO, CA (AP). ImmunityBio, Inc., (IBRX), reported a $116.3-million loss in the first quarter.
The San Diego company reported a loss per share of 27 cents.
The company's revenue for the period was $360,000.
This story was created by
Zacks Investment Research data. Access to a
Zacks Stock Report on IBRX
You can also check out our Facebook page.